Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, have developed a new computational tool to screen patients with common but blinding retinal diseases, potentially speeding diagnoses and treatment.
The findings are published in the February 22 issue of Cell.
“Artificial intelligence (AI) has huge potential to revolutionize disease diagnosis and management by doing analyses and classifications involving immense amounts of data that are difficult for human experts — and doing them rapidly,” said senior author Kang Zhang, MD, PhD, professor of ophthalmology at Shiley Eye Institute and founding director of the Institute for Genomic Medicine at UC San Diego School of Medicine.
Current computational approaches are laborious and expensive, and require using millions of images to train an AI system. In their new paper, Zhang and colleagues used an AI-based convolutional neural network to review more than 200,000 eye scans conducted with optical coherence tomography, a noninvasive technology that bounces light off the retina to create two- and three-dimensional representations of tissue.
The researchers then employed a technique called transfer learning in which knowledge gained in solving one problem is stored by a computer and applied to different but related problems. For example, an AI neural network optimized to recognize the discrete anatomical structures of the eye, such as the retina, cornea or optic nerve, can more quickly and efficiently identify and evaluate them when examining images of a whole eye. This allows the AI system to learn effectively with a much smaller dataset than traditional methods.
The researchers next added occlusion testing in which the computer identifies the areas in each image that are of greatest interest and the basis for its conclusions. “Machine learning is often like a black box where we don’t know exactly what is happening,” Zhang said. “With occlusion testing, the computer can tell us where it is looking in an image to arrive at a diagnosis, so we can figure out why the system got the result it did. This makes the system more transparent and increases our trust in the diagnosis.”
The study focused on two common causes of irreversible blindness: macular degeneration and diabetic macular edema. Both conditions, however, are treatable if detected early. Machine-derived diagnoses were compared with diagnoses from five ophthalmologists who reviewed the same scans. In addition to making a medical diagnosis, the AI platform also generated a referral and treatment recommendation not done in previous studies.
With simple training, the authors noted, the machine performed similar to a well-trained ophthalmologist, and could generate a decision on whether or not the patient should be referred for treatment within 30 seconds, with more than 95 percent accuracy.
Such speed and accuracy would represent a profound step forward in medical diagnoses and treatment, according to Zhang, noting that current health care is often lengthy as patients are referred from general physicians to specialists, consuming time and resources and delaying effective treatment. Zhang also noted that a simplified and relatively inexpensive AI-based tool would be a boon in places and parts of the world where medical resources, particularly specialists, are scarce.
The scientists did not limit their study to eye diseases. They also tested their AI tool in diagnosing childhood pneumonia, a leading cause of death worldwide in children under the age of 5, based on machine analyses of chest X-rays. They found that the computer was able to differentiate between viral and bacterial pneumonia with greater than 90 percent accuracy. Viral pneumonia is treated primarily with symptomatic care as the body naturally rids itself of the virus. Bacterial pneumonia tends to be a more serious health threat and requires immediate treatment with antibiotics.
Zhang said the findings show that the AI technology has many potential applications, including perhaps discerning between benign and malignant lesions detected on scans. The scientists have open-sourced published their data and tool so that others can further improve, refine and develop its potential.
“The future is more data, more computational power and more experience of the people using this system so that we can provide the best patient care possible, while still being cost-effective,” Zhang said.
The Latest on: Disease diagnosis using artificial intelligence
Artificial intelligence in healthcare ‘set for 40% growth to 2024’
on April 13, 2018 at 2:53 am
The market for artificial ... disease diagnosis and monitoring”. In 2016 drug discovery accounted for just over a third (35%) of the market, and will grow by 40% year-on-year over the study period to become the largest market segment, as researchers use ... […]
What Facebook’s public scrutiny can teach us about artificial intelligence in health care
on April 11, 2018 at 8:45 am
For example, if an algorithm is repeatedly fed information about a certain disease among black patients without ... But if we are to move forward with the use of artificial intelligence to help physicians and other care providers make clinical decisions ... […]
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
on April 11, 2018 at 8:15 am
April 11, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence ... or diagnosis of a life-threatening or irreversibly debilitating disease or condition ... […]
A Chinese hospital is betting big on artificial intelligence to treat patients
on April 4, 2018 at 3:58 am
Now, a hospital in the southern metropolis of Guangzhou is looking to relieve the problem with artificial intelligence ... this week (link in Chinese). Using WeChat, the chat app owned by Tencent, users can get a pre-diagnosis through the hospital ... […]
Artificial intelligence diagnoses eye diseases
on March 3, 2018 at 10:29 am
Through the use of a new computational tool diagnoses ... According to lead researcher Professor Kang Zhang: "Artificial intelligence (AI) has huge potential to revolutionize disease diagnosis and management by doing analyses and classifications involving ... […]
The Manton Center at Boston Children’s Hospital and Alexion Pharmaceuticals Partner in Artificial Intelligence Approaches to Rare Disease Diagnosis
on February 27, 2018 at 3:49 am
The Manton Center for Orphan Disease Research, the Innovation and Digital Health Accelerator at Boston Children’s Hospital, and Alexion Pharmaceuticals ... to train the artificial intelligence engine within 20RDQ to improve diagnosis speed and accuracy ... […]
Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia
on February 21, 2018 at 4:00 pm
"Artificial intelligence (AI) has huge potential to revolutionize disease diagnosis and management by doing analyses ... Current computational approaches are laborious and expensive, and require using millions of images to train an AI system. […]
Artificial Intelligence Could Predict Alzheimer's Disease Years Before Symptoms Begin
on September 2, 2017 at 7:26 pm
Artificial intelligence ... by using AI techniques and big data to build an algorithm that can recognize signs of dementia two years in advance. Researchers used a single amyloid PET scan of the brain of patients at risk of developing Alzheimer’s disease ... […]
via Google News and Bing News